Immunoaffinity profiling of tyrosine phosphorylation in cancer cells

John Rush1, Albrecht Moritz, Kimberly A Lee

  • 1Cell Signaling Technology Inc., 166B Cummings Center, Beverly, Massachusetts 01915, USA.

Nature Biotechnology
|December 14, 2004
PubMed

Insights

Identifying cancer signaling pathways is challenging. This study presents a new phosphoproteomic strategy to identify tyrosine phosphorylation sites, revealing activated protein kinases and substrates for cancer research.

Area of Science:

  • Biochemistry
  • Oncology
  • Proteomics

Background:

  • Tyrosine kinases are crucial in human cancer, regulating cell proliferation and survival.
  • Identifying specific oncogenic signaling pathways is difficult due to pathway complexity and low phosphotyrosine levels.
  • Existing phosphoproteomic methods identify limited phosphotyrosine peptides.

Purpose of the Study:

  • To develop an improved strategy for identifying tyrosine phosphorylation sites.
  • To enhance the understanding of signaling networks in normal and cancerous cells.
  • To identify activated protein kinases and their substrates without prior pathway knowledge.

Main Methods:

  • Developed a strategy emphasizing the phosphotyrosine component of the phosphoproteome.
  • Isolated phosphotyrosine-containing peptides from protease-digested cell extracts using a specific antibody.
  • Identified peptides using tandem mass spectrometry.

Main Results:

  • Successfully identified a large number of tyrosine phosphorylation sites.
  • Demonstrated the ability to identify activated protein kinases and their phosphorylated substrates.
  • Applied the approach to various cell systems, including cancer cell lines.

Conclusions:

  • The developed phosphoproteomic strategy effectively identifies tyrosine phosphorylation sites.
  • This method facilitates the profiling of normal and oncogenic signaling networks.
  • Enables the discovery of activated kinases and substrates, advancing cancer research.

Related Concept Videos